Pulmonary Arterial Hypertension and Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Novel Association?
Pulmonary Arterial Hypertension and Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Novel Association?
复制标题
肺动脉高压与胰腺导管内乳头状粘液性肿瘤:一种新的关联?
DOI:
10.1016/j.chest.2021.06.078
复制
发表时间:
2021
期刊:
影响因子:
9.6
通讯作者:
Bull,ToddM
中科院分区:
文献类型:
--
作者:
Lee,MichaelH;Doran,Jennifer;Bang,TamiJ;Hohsfield,Robin;Hountras,Peter;Boddie,Genevieve;Wagh,MihirS;Badesch,David;Bull,ToddM
MethodsWe highlight key characteristics of six patients from the pulmonary hypertension clinic at the University of Colorado, all managed for≥ 10 years with PAH, who were subsequently diagnosed with IPMN based on radiographic features. We also discuss unique aspects of clinical management and propose potential unifying mechanisms underlying both diseases.ResultsWe identified six PAH patients treated at the University of Colorado Hospital between 1996 and 2021, four with IPAH, one with portopulmonary hypertension, and one with PAH caused by undifferentiated systemic rheumatic disease. Our clinic sees approximately 3,000 visits annually; of these, approximately 65 newly referred patients are diagnosed with PAH each year. These six patients had severe pulmonary hypertension requiring multiple medications, including IV prostacyclin (PGI 2) analog therapy for many (14±4.9 years (Table 1). The most common symptoms included abdominal pain, diarrhea, nausea, vomiting, weight loss, anorexia, and fatigue. Evidence of IPMN was seen on CT or magnetic resonance cholangiopancreatography (MRCP)(Fig 1).